Disease | open-angle glaucoma |
Symptom | C0021888|intraocular pressure |
Sentences | 65 |
PubMedID- 23269858 | Background: this study was designed to evaluate the occurrence and severity of ocular hyperemia in subjects with elevated intraocular pressure (iop) due to primary open angle glaucoma (poag) or ocular hypertension (oht) following treatment with bimatoprost 0.01% in a real-world clinical setting. |
PubMedID- 23009074 | Goldmann applanation tonometry compared with corneal-compensated intraocular pressure in the evaluation of primary open-angle glaucoma. |
PubMedID- 21849211 | Among the remaining studies, level ii evidence supports the efficacy of selective laser trabeculoplasty for lowering intraocular pressure for patients with open-angle glaucoma. |
PubMedID- 24771165 | Results: two patients with primary open-angle glaucoma underwent canaloplasty because of medically uncontrolled intraocular pressure (iop). |
PubMedID- 23111175 | Purpose: to investigate the effect of change of body posture from the supine to the lateral decubitus position on intraocular pressure (iop) in patients with open-angle glaucoma. |
PubMedID- 25016793 | Transient increase of intraocular pressure with primary open angle glaucoma patients associated with warm and cold seasons after long waiting time in an ophthalmology clinic. |
PubMedID- 26155078 | Methods: ninety adult male/female patients of 18-60 years of age, of either sex, suffering from open angle glaucoma with an intraocular pressure (iop) of more than 24 mm hg were enrolled in the study. |
PubMedID- 23218823 | Purpose: to compare the change in lamina cribrosa (lc) displacement in response to intraocular pressure (iop) lowering in patients with open-angle glaucoma (oag) using spectral-domain optical coherence tomography (sd-oct). |
PubMedID- 24735011 | Results: eighty open-angle glaucoma with normal baseline intraocular pressure patients and 4015 controls were included. |
PubMedID- 20390038 | Clinical studies have demonstrated its efficacy at decreasing intraocular pressure in patients with open-angle glaucoma or ocular hypertension. |
PubMedID- 24204049 | Changes in the lamina and prelamina after intraocular pressure reduction in patients with primary open-angle glaucoma and acute primary angle-closure. |
PubMedID- 20225997 | Primary open angle glaucoma without satisfying intraocular pressure (iop) control (> or =21 mmhg) despite maximally tolerated medication or with progression of the visual field and cataract was the indication for surgery. |
PubMedID- 21543995 | Purpose: to compare the longitudinal change of frequency doubling technology (fdt) perimetry and standard automated perimetry (sap) results in sap-normal hemifield in open-angle glaucoma (oag) eyes with low-to-normal intraocular pressure (iop). |
PubMedID- 21873661 | A population-based assessment of 24-hour intraocular pressure among subjects with primary open-angle glaucoma: the handan eye study. |
PubMedID- 21216796 | The authors report their initial clinical results with a novel wireless ocular telemetry sensor (ots) (sensimed ag, switzerland) for continuous intraocular pressure (iop) monitoring in patients with open angle glaucoma. |
PubMedID- 22553666 | Head trauma can cause transient elevation of intraocular pressure in patients with open angle glaucoma. |
PubMedID- 21479271 | One of the most common forms of glaucoma, primary open angle glaucoma, is associated with increased intraocular pressure. |
PubMedID- 24286181 | Purpose: the purpose of the present study was to elucidate the effects of several anti-glaucoma medications on the circadian intraocular pressure (iop) fluctuations in patients with primary open-angle glaucoma (poag). |
PubMedID- 24689838 | Conclusions: uc(3) procedure seems to be an effective and well tolerated method to reduce intraocular pressure in patients with primary open-angle glaucoma. |
PubMedID- 25639001 | Methods: a total of 52 eyes from 52 open-angle glaucoma (oag) patients, with elevated intraocular pressure (lop), were included in this cross-sectional study. |
PubMedID- 26286384 | Conclusions: both slt and topical medication demonstrate similar success rates and effectiveness in lowering intraocular pressure in patients with open-angle glaucoma. |
PubMedID- 25719238 | Purpose:: to describe a new association between nonsenile nuclear cataracts and pigmentary glaucoma in patients with controlled intraocular pressure (iop). |
PubMedID- 24882991 | Latanoprost 0.005% has received the european and the us approval as the first-line drug reducing the intraocular pressure in patients with open angle glaucoma or ocular hypertension. |
PubMedID- 25897195 | It is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers.1 the side effects of topical dorzolamide hydrochloride, such as conjunctivitis, eyelid edema, and eye lid irritation, are well known.2 however, allergic contact dermatitis due to dorzolamide is rare, although it has been commonly used worldwide in patients with glaucoma. |
PubMedID- 24822212 | Background: to investigate the efficacy of selective laser trabeculoplasty (slt) for lowering intraocular pressure (iop) in patients with open angle glaucoma (oag) secondary to emulsified silicone oil (so). |
PubMedID- 22320418 | Purpose: to compare the efficacy and safety of dorzolamide hydrochloride 2%/timolol maleate 0.5% fixed combination (dtfc) with latanoprost 0.005%/timolol maleate 0.5% fixed combination (ltfc) on diurnal intraocular pressure (iop) in patients with primary open-angle glaucoma. |
PubMedID- 22167545 | Purpose: to assess the retrobulbar hemodynamic parameters in the ophthalmic artery (oa), central retinal artery (cra), and short posterior ciliary arteries (pca) after decreasing elevated intraocular pressure (iop) in patients with open-angle glaucoma (oag) by using color doppler imaging. |
PubMedID- 23835670 | Purpose: to evaluate the efficacy of selective laser trabeculoplasty (slt) versus argon laser trabeculoplasty (alt) in lowering the intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension secondary to pseudoexfoliation. |
PubMedID- 22140308 | However, their intake, particularly that of coffee, has been suggested to increase intraocular pressure (iop) in patients with open angle glaucoma/ocular hypertension. |
PubMedID- 21127505 | Purpose: to investigate factors associated with changes in optic nerve head (onh) topography after acute intraocular pressure (iop) reduction in patients with primary open-angle glaucoma (poag). |
PubMedID- 24059679 | Of 1,589 eligible people, we detected 284 (17.9%) cases of glaucoma overall, including 36 (2.3%) cases of primary open-angle glaucoma with intraocular pressure levels greater than 21 mmhg, 226 (14.2%) cases of normal-tension glaucoma and 25 (1.6%) cases of primary angle-closure glaucoma. |
PubMedID- 21468336 | Several different classes of drugs are available for the reduction of elevated intraocular pressure (iop) associated with open-angle glaucoma or ocular hypertension, including β-blockers, carbonic anhydrase inhibitors (cais), prostaglandin analogs (pgas), and α-2 agonists. |
PubMedID- 21437058 | Bimatoprost ophthalmic solution 0.03% (lumigan®; allergan, inc.) was initially developed as an ocular antihypertensive and, in 2001, was approved for the reduction of elevated intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension.19 as a glaucoma treatment, bimatoprost ophthalmic solution 0.03% is administered as a drop into the affected eye once daily. |
PubMedID- 22613602 | Effect of high myopia on 24-hour intraocular pressure in patients with primary open-angle glaucoma. |
PubMedID- 20590394 | Primary open-angle glaucoma without satisfying intraocular pressure (iop) control (>or=21 mmhg) despite maximally tolerated medications or with progression of visual field and cataract was the indication for surgery. |
PubMedID- 25213118 | The intraocular pressure (iop) reduction with taf/tim in open-angle glaucoma and ocular hypertension is similar to that of other prostaglandin-timolol fixed-combination products. |
PubMedID- 24232829 | Design, setting, and participants: prospective clinical cohort study at kumamoto university hospital, kumamoto, japan, among patients 55 years or older having open-angle glaucoma with intraocular pressure (iop) of 22 mm hg or higher, including 39 phakic eyes (phakic group) and 25 pseudophakic eyes after phacoemulsification (pseudophakic group). |
PubMedID- 23293509 | Among these drugs, prostaglandin f2α (pgf2α) analogs have become the first-line agents in treating open angle glaucoma because of their reliable intraocular pressure-lowering effect, good compliance (once daily application), and fewer side effects. |
PubMedID- 24481483 | Objective to assess the effectiveness of intraocular pressure (iop)-lowering medications in patients with open-angle glaucoma. |
PubMedID- 26107474 | The effects of fixed combination of bimatoprost-timolol and travoprost-timolol on intraocular pressure in patients with primary open-angle glaucoma or ocular hypertension, previously on nonfixed combination of latanoprost and timolol. |
PubMedID- 24027965 | The effect of crystalline lens extraction on intraocular pressure in patients with primary open-angle glaucoma. |
PubMedID- 21048514 | Aim: to evaluate the efficacy and tolerability of flunarizine, a nonselective calcium channel blocker, on intraocular pressure (iop) in patients with open-angle glaucoma (oag) or ocular hypertension (oh). |
PubMedID- 23111749 | Background: we evaluated the relation of systemic blood pressure with intraday variations in ocular perfusion pressure and intraocular pressure in patients with primary open-angle glaucoma in a telemedical home monitoring scenario. |
PubMedID- 24653751 | intraocular pressure after phacoemulsification in patients with uncontrolled primary open angle glaucoma. |
PubMedID- 24558609 | To evaluate the short-term effect of standard automated perimetry (sap) testing on intraocular pressure (iop) in patients with open-angle glaucoma (oag). |
PubMedID- 22171066 | Primary open-angle glaucoma is associated with elevated intraocular pressure, which in turn is believed to result from impaired outflow of aqueous humour. |
PubMedID- 21104187 | Background: to determine if asymmetrical postural change-induced elevations in intraocular pressure (iop) in eyes of patients with primary open-angle glaucoma (poag) were associated with asymmetries in functional and structural damage. |
PubMedID- 25088623 | The elevated intraocular pressure (iop) of primary open-angle glaucoma is caused by impaired outflow of aqueous humor through the trabecular meshwork. |
PubMedID- 25276082 | Purpose: to compare the efficacy and safety of latanoprost, bimatoprost, travoprost and timolol in reducing intraocular pressure (iop) in patients with primary open angle glaucoma. |
PubMedID- 21995983 | Objective: selective laser trabeculoplasty (slt) and argon laser trabeculoplasty (alt) are used to lower intraocular pressure (iop) in patients with open-angle glaucoma (oag). |
Page: 1 2